Connection

Inderjit Singh to Fatty Acids

Back to Details
This is a "connection" page, showing publications Inderjit Singh has written about Fatty Acids.
Inderjit Singh
Connection Strength
4.098
Fatty Acids
  1. HDAC inhibitor SAHA normalizes the levels of VLCFAs in human skin fibroblasts from X-ALD patients and downregulates the expression of proinflammatory cytokines in Abcd1/2-silenced mouse astrocytes. J Lipid Res. 2011 Nov; 52(11):2056-69.
    View in: PubMed
    Score: 0.364
  2. Very long-chain fatty acid accumulation causes lipotoxic response via 5-lipoxygenase in cerebral adrenoleukodystrophy. J Lipid Res. 2010 Jul; 51(7):1685-95.
    View in: PubMed
    Score: 0.327
  3. Correlation of very long chain fatty acid accumulation and inflammatory disease progression in childhood X-ALD: implications for potential therapies. Neurobiol Dis. 2003 Dec; 14(3):425-39.
    View in: PubMed
    Score: 0.212
  4. Peroxisomal fatty acid oxidation and cellular redox. Methods Enzymol. 2002; 352:361-72.
    View in: PubMed
    Score: 0.186
  5. Identification of the pathway of alpha-oxidation of cerebronic acid in peroxisomes. Lipids. 2000 Oct; 35(10):1127-33.
    View in: PubMed
    Score: 0.171
  6. Endotoxin-induced alterations of lipid and fatty acid compositions in rat liver peroxisomes. J Endotoxin Res. 2000; 6(1):41-50.
    View in: PubMed
    Score: 0.162
  7. Cytokine-induced accumulation of very long-chain fatty acids in rat C6 glial cells: implication for X-adrenoleukodystrophy. J Neurochem. 1998 Jul; 71(1):78-87.
    View in: PubMed
    Score: 0.146
  8. Therapy for X-adrenoleukodystrophy: normalization of very long chain fatty acids and inhibition of induction of cytokines by cAMP. J Lipid Res. 1998 May; 39(5):1091-100.
    View in: PubMed
    Score: 0.144
  9. Lovastatin and sodium phenylacetate normalize the levels of very long chain fatty acids in skin fibroblasts of X- adrenoleukodystrophy. FEBS Lett. 1998 Apr 24; 426(3):342-6.
    View in: PubMed
    Score: 0.144
  10. Biochemistry of peroxisomes in health and disease. Mol Cell Biochem. 1997 Feb; 167(1-2):1-29.
    View in: PubMed
    Score: 0.132
  11. Functional Characterization of IPSC-Derived Brain Cells as a Model for X-Linked Adrenoleukodystrophy. PLoS One. 2015; 10(11):e0143238.
    View in: PubMed
    Score: 0.122
  12. Oral administration of cytosolic PLA2 inhibitor arachidonyl trifluoromethyl ketone ameliorates cauda equina compression injury in rats. J Neuroinflammation. 2015 May 15; 12:94.
    View in: PubMed
    Score: 0.117
  13. ABCD1 deletion-induced mitochondrial dysfunction is corrected by SAHA: implication for adrenoleukodystrophy. J Neurochem. 2015 May; 133(3):380-96.
    View in: PubMed
    Score: 0.115
  14. Purification of peroxisomes and subcellular distribution of enzyme activities for activation and oxidation of very-long-chain fatty acids in rat brain. Biochim Biophys Acta. 1993 Sep 29; 1170(1):44-52.
    View in: PubMed
    Score: 0.105
  15. Histone deacetylase inhibitor upregulates peroxisomal fatty acid oxidation and inhibits apoptotic cell death in abcd1-deficient glial cells. PLoS One. 2013; 8(7):e70712.
    View in: PubMed
    Score: 0.104
  16. Transport of fatty acids into human and rat peroxisomes. Differential transport of palmitic and lignoceric acids and its implication to X-adrenoleukodystrophy. J Biol Chem. 1992 Jul 05; 267(19):13306-13.
    View in: PubMed
    Score: 0.096
  17. Peroxisomal activation, transport and oxidation of fatty acids: implications to peroxisomal disorders. Prog Clin Biol Res. 1992; 375:211-22.
    View in: PubMed
    Score: 0.093
  18. Effect of ciprofibrate on the activation and oxidation of very long chain fatty acids. Mol Cell Biochem. 1991 Feb 02; 100(2):159-67.
    View in: PubMed
    Score: 0.087
  19. Pathomechanisms underlying X-adrenoleukodystrophy: a three-hit hypothesis. Brain Pathol. 2010 Jul; 20(4):838-44.
    View in: PubMed
    Score: 0.084
  20. Cellular oxidation of lignoceric acid is regulated by the subcellular localization of lignoceroyl-CoA ligases. J Lipid Res. 1990 Apr; 31(4):583-95.
    View in: PubMed
    Score: 0.082
  21. Lipid peroxidation and oxidation of lignoceric acid in kidneys from thioridazine treated rats. J Exp Pathol. 1990; 5(4):177-86.
    View in: PubMed
    Score: 0.081
  22. Adrenoleukodystrophy: impaired oxidation of fatty acids due to peroxisomal lignoceroyl-CoA ligase deficiency. Arch Biochem Biophys. 1989 May 01; 270(2):722-8.
    View in: PubMed
    Score: 0.077
  23. Oxidative imbalance in nonstimulated X-adrenoleukodystrophy-derived lymphoblasts. Dev Neurosci. 2008; 30(6):410-8.
    View in: PubMed
    Score: 0.076
  24. Effect of fatty acids and their derivatives on mitochondrial structures. J Exp Pathol. 1989; 4(1):9-15.
    View in: PubMed
    Score: 0.076
  25. Peroxisomal lignoceroyl-CoA ligase deficiency in childhood adrenoleukodystrophy and adrenomyeloneuropathy. Proc Natl Acad Sci U S A. 1988 Oct; 85(20):7647-51.
    View in: PubMed
    Score: 0.074
  26. Fatty acid metabolism in renal ischemia. Lipids. 1988 Sep; 23(9):882-4.
    View in: PubMed
    Score: 0.074
  27. Effect of salicylic acid on mitochondrial-peroxisomal fatty acid catabolism. Pediatr Res. 1988 Mar; 23(3):338-41.
    View in: PubMed
    Score: 0.071
  28. Impaired peroxisomal function in the central nervous system with inflammatory disease of experimental autoimmune encephalomyelitis animals and protection by lovastatin treatment. Brain Res. 2004 Oct 01; 1022(1-2):1-11.
    View in: PubMed
    Score: 0.056
  29. A novel role of lactosylceramide in the regulation of lipopolysaccharide/interferon-gamma-mediated inducible nitric oxide synthase gene expression: implications for neuroinflammatory diseases. J Neurosci. 2004 Jun 30; 24(26):5942-54.
    View in: PubMed
    Score: 0.055
  30. Lovastatin therapy for X-linked adrenoleukodystrophy: clinical and biochemical observations on 12 patients. Mol Genet Metab. 2000 Apr; 69(4):312-22.
    View in: PubMed
    Score: 0.041
  31. Localization of nervonic acid beta-oxidation in human and rodent peroxisomes: impaired oxidation in Zellweger syndrome and X-linked adrenoleukodystrophy. J Lipid Res. 1998 Nov; 39(11):2161-71.
    View in: PubMed
    Score: 0.037
  32. Abnormality in catalase import into peroxisomes leads to severe neurological disorder. Proc Natl Acad Sci U S A. 1998 Mar 17; 95(6):2961-6.
    View in: PubMed
    Score: 0.036
  33. Phytanic acid alpha-oxidation in rat liver mitochondria. Biochim Biophys Acta. 1994 Dec 15; 1201(3):491-7.
    View in: PubMed
    Score: 0.029
  34. Impairment of peroxisomal beta-oxidation system by endotoxin treatment. Mol Cell Biochem. 1994 Jun 29; 135(2):187-93.
    View in: PubMed
    Score: 0.028
  35. The protein coded by the X-adrenoleukodystrophy gene is a peroxisomal integral membrane protein. FEBS Lett. 1994 May 16; 344(2-3):211-5.
    View in: PubMed
    Score: 0.027
  36. Alterations of peroxisomal function in ischemia-reperfusion injury of rat kidney. Biochim Biophys Acta. 1993 Oct 20; 1182(3):291-8.
    View in: PubMed
    Score: 0.026
  37. Refsum disease: a defect in the alpha-oxidation of phytanic acid in peroxisomes. J Lipid Res. 1993 Oct; 34(10):1755-64.
    View in: PubMed
    Score: 0.026
  38. Phytanic acid alpha-oxidation. Differential subcellular localization in rat and human tissues and its inhibition by nycodenz. J Biol Chem. 1993 May 15; 268(14):9972-9.
    View in: PubMed
    Score: 0.026
  39. Phytanic acid alpha-oxidation in human cultured skin fibroblasts. Biochim Biophys Acta. 1992 Dec 10; 1180(2):221-4.
    View in: PubMed
    Score: 0.025
  40. Ischemia-reperfusion injury: biochemical alterations in peroxisomes of rat kidney. Arch Biochem Biophys. 1992 May 15; 295(1):90-100.
    View in: PubMed
    Score: 0.024
  41. Complementation in Zellweger syndrome: biochemical analysis of newly generated peroxisomes. Hum Hered. 1992; 42(3):172-8.
    View in: PubMed
    Score: 0.023
  42. Rhizomelic chondrodysplasia punctata: biochemical studies of peroxisomes isolated from cultured skin fibroblasts. Arch Biochem Biophys. 1991 Apr; 286(1):277-83.
    View in: PubMed
    Score: 0.022
  43. Postnatal development and isolation of peroxisomes from brain. J Neurochem. 1991 Apr; 56(4):1343-53.
    View in: PubMed
    Score: 0.022
  44. Effect of clofibrate on peroxisomal lignoceroyl-CoA ligase activity. Biochem Med Metab Biol. 1990 Feb; 43(1):22-9.
    View in: PubMed
    Score: 0.020
  45. Reye syndrome: rate of oxidation of fatty acids in leukocytes and serum levels of lipid peroxides. J Exp Pathol. 1989; 4(3):133-9.
    View in: PubMed
    Score: 0.019
  46. Acyl-CoA ligases from rat brain microsomes: an immunochemical study. Biochim Biophys Acta. 1988 Dec 16; 963(3):509-14.
    View in: PubMed
    Score: 0.019
  47. Peroxisomal participation in psychosine-mediated toxicity: implications for Krabbe's disease. J Neurosci Res. 2005 Jun 15; 80(6):845-54.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.